Avanir Pharmaceuticals (AVNR) Misses Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts AVNR Hot Sheet
Price: $16.96 --0%
Financial Fact:
Total operating expenses: 40.52M
Today's EPS Names:
MTEX, NSYS, PLNH, More
Financial Fact:
Total operating expenses: 40.52M
Today's EPS Names:
MTEX, NSYS, PLNH, More
Join SI Premium – FREE
Avanir Pharmaceuticals (NASDAQ: AVNR) reported Q1 EPS of ($0.09), $0.01 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $16.5 million, versus $7.2 million reported last year.
For earnings history and earnings-related data on Avanir Pharmaceuticals (AVNR) click here.
For earnings history and earnings-related data on Avanir Pharmaceuticals (AVNR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- Marchex (MCHX) Reports In-Line Q2 EPS
- Pan American Silver (PAAS) Misses Q2 EPS by 19c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
